Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

Turnstone Biologics Corp. (TSBX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

2.7200

+0.1100

(+4.21%)

At close: 04:00PM EDT

2.8700

+0.15

(+5.51%)

After hours:

06:44PM EDT

Trade prices are not sourced from all markets

All

GlobeNewswire
Turnstone Biologics Appoints William Waddill to its Board of Directors
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced the appointment of industry veteran William Waddill to the Company’s Board of Directors. The Company also announced that Patrick Machado has stepped down as a member o
GlobeNewswire
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
Lead program, TIDAL-01, advancing in Phase 1 trials with initial clinical data expected in mid-2024 Promising preclinical data highlighting Turnstone’s novel Selected TIL programs for solid tumors presented at SITC 2023 Further strengthened Scientific Advisory Board with appointment of internationally recognized cancer immunotherapy expert, Dr. Jeffrey S. Weber SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage
Simply Wall St.
Turnstone Biologics Corp. (NASDAQ:TSBX) institutional investors have had a good week as stock gains 34%
Key Insights Given the large stake in the stock by institutions, Turnstone Biologics' stock price might be vulnerable...